HjerneStim.no

tDCS - Transcranial direct current stimulation 

A small, handy brain stimulator for home use

Safe treatment method with few, mild side-effects 

Evidence based treatment for depression, migraine, fibromyalgia and early dementia

Individually designed treatment program from Jill Hervik PhD - tDCS researcher and pain specialist 

Use on its own or combined with other treatments 

Hundreds of patients have effectively been treated with tDCS for headaches at a leading Norwegian Hospital  


            

              


DAGENS MEDISIN - (TODAYS MEDICINE) a study carried out at Vestfold Hospital Trust, Pain Clinic, Norway, demonstrated that brain stimulation with tDCS is effective for patients with tension headache. Study leader: Jill Hervik PhD
DAGENS MEDISIN - (TODAYS MEDICINE) a study carried out at Vestfold Hospital Trust, Pain Clinic, Norway, demonstrated that brain stimulation with tDCS is effective for patients with tension headache. Study leader: Jill Hervik PhD

What is tDCS?

tDCS emits a weak electrical current via electrodes attached to the scalp to target spesific brain areas 

Electrical stimulation adjusts the activity of targeted brain cells by reducing resistance around cell membranes 

Substances needed for optimal function move more easily into the cells

No serious side-effects

Painless, easily tolerated treatment 

Treatment time: 20-30 minutes

Simple to use in the comfort of your own home

Get detailed information regarding electrode placement for your specific symptoms/condition

Learn how you can combine tDCS with other therapies/approaches for best effect 

Follow us on social media for regular research updates



Depression

tDCS can be used on its own or in combination with conventional treatment.  According to an article published by the Norwegian Health Institute, where results from 25 studies were combined, tDCS is an effective treatment  for patients suffering from moderate to serious conditions of depression. Furthermore, relapse rates are significantly reduced. https://www.fhi.no/publ/2022/transkraniell-likestromsbehandling-for-depresjon-og-afasi/#:

Headache/Migraine

 Researcher Dr.med. Jill Hervik from Vestfold Hospital Trust, headed a study which examined the effect of tDCS on patients with chronic tension headaches. Participants who received the active tDCS treatment experienced a significant increase in their levels of daily function (40%) and a considerable reduction in headache intensity (45%).   https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2024.1353987/full

The National Institutes of Health:  "TDCS is an effective, preventative and safe treatment for migraine."   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160451/

Cognitive failure - Alzheimers/Lewy Body Dementia

Several neurostimulation techniques including tDCS have shown positive results in patients suffering from early Alzheimers. Improvements in memory, language and other specific cognitive functions were recorded in 2 different meta-analyses from 2018 and 2022. The most positive results were observed when treatment  was combined with mental training and physical activity.   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262447/

Consentration and memory skills increase in healthy individuals after tDCS treatment, it is therefore likely that tDCS also has a preventative effect. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377527/

Fibromyalgia

The cause of fibromyalgia continues to delude scientists and doctors alike. However, recent experimental research has identified reduced levels of several neuro-transmitters in the brain including levels of Dopamine, the "feel good" hormone, and Serotonin, which is important for pain relief, mood, digestion and sleep. In contrast higher levels of the stress hormone Cortisol have been measured in urine samples of patients with fibromyalgia. tDCS can address several of these imbalances. Advantageous biochemical changes and improved signalling between brain cells in the front part of the brain have been measured after tDCS.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10865494/